Imatinib Mesylate (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Imatinib Mesylate drug offered from Mylan Pharmaceuticals Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | imatinib |
| SUBSTANCE NAME: | IMATINIB MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-28 |
| END MARKETING DATE: | 0000-00-00 |
Imatinib Mesylate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Imatinib Mesylate from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2017-09-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-2245_23847256-e20d-4ab5-a1da-fdab5c94ca0c |
| PRODUCT NDC: | 0378-2245 |
| APPLICATION NUMBER: | ANDA204644 |
Other IMATINIB MESYLATE Pharmaceutical Manufacturers / Labelers:
